| pubmed-article:2574646 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C0037659 | lld:lifeskim |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C0037663 | lld:lifeskim |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C1154417 | lld:lifeskim |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C0018517 | lld:lifeskim |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C0205227 | lld:lifeskim |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C0205228 | lld:lifeskim |
| pubmed-article:2574646 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:2574646 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2574646 | pubmed:dateCreated | 1990-1-31 | lld:pubmed |
| pubmed-article:2574646 | pubmed:abstractText | We have estimated the half-life of serum growth hormone (GH) in six subjects on 14 occasions following an intravenous bolus injection of either 50 or 500 mU of biosynthetic human growth hormone (B-hGH) while endogenous GH secretion was suppressed by a continuous infusion of somatostatin. The disappearance curve of serum GH was mono-exponential and the mean half-life was 8.9 min (SD 1.5). This is less than previously reported and has important implications for the performance of GH profiles, which should be performed with 10-15 min sampling intervals, and the calculation of pituitary GH secretion rates. | lld:pubmed |
| pubmed-article:2574646 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2574646 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2574646 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2574646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2574646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2574646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2574646 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2574646 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:2574646 | pubmed:issn | 0300-0664 | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:MatthewsD RDR | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:BrookC GCG | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:KurtzA BAB | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:BruckSS | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:HindmarshP... | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:PringleP JPJ | lld:pubmed |
| pubmed-article:2574646 | pubmed:author | pubmed-author:di SilvioLL | lld:pubmed |
| pubmed-article:2574646 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2574646 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:2574646 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2574646 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2574646 | pubmed:pagination | 443-50 | lld:pubmed |
| pubmed-article:2574646 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:meshHeading | pubmed-meshheading:2574646-... | lld:pubmed |
| pubmed-article:2574646 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2574646 | pubmed:articleTitle | The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin. | lld:pubmed |
| pubmed-article:2574646 | pubmed:affiliation | Endocrine Unit, Middlesex Hospital, London, UK. | lld:pubmed |
| pubmed-article:2574646 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2574646 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2574646 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2574646 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2574646 | lld:pubmed |
